Patents by Inventor Omar Laterza

Omar Laterza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers for brain damage
    Patent number: 9982299
    Abstract: Methods to identify markers for brain damage using fresh brain tissue and methods and compositions for detecting these markers are disclosed.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: May 29, 2018
    Assignee: Washington University
    Inventors: Jack Ladenson, Yvonne Landt, Vijay Modur, Omar Laterza
  • Immunoassay for soluble PD-L1
    Patent number: 9535074
    Abstract: The present disclosure describes two matched antibody pairs for use in a sandwich immunoassay for detecting and quantifying soluble PD-L1 in liquid samples, as well as an electrochemiluminescence sandwich immunoassay that has been optimized and validated with one of the matched pairs.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: January 3, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Gulesi Ayanoglu, Xiaoyan Du, Jr., Vinita Gupta, Omar Laterza, Linda Liang, Eric Rimmer
  • ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES
    Publication number: 20160356794
    Abstract: The present invention provides novel antibodies that bind to human Tau and assays for quantifying human Tau using these antibodies.
    Type: Application
    Filed: February 9, 2015
    Publication date: December 8, 2016
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Omar Laterza, Michael Tanen, Oitak Wong
  • IMMUNOASSAY FOR SOLUBLE PD-L1
    Publication number: 20160069900
    Abstract: The present disclosure describes two matched antibody pairs for use in a sandwich immunoassay for detecting and quantifying soluble PD-L1 in liquid samples, as well as an electrochemiluminescence sandwich immunoassay that has been optimized and validated with one of the matched pairs.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 10, 2016
    Inventors: Gulesi Ayanoglu, Xiaoyan Du, JR., Vinita Gupta, Omar Laterza, Linda Liang, Eric Rimmer
  • ALZHEIMER'S DIAGNOSIS
    Publication number: 20130288280
    Abstract: Evaluation of VLP-1 levels in combination with at least one of amyloid-? peptide (A?), hyperphosphorylated tau (pTau) or total tau (tTau) levels in samples of biological fluid improves the accuracy of diagnosis of Alzheimer's disease.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 31, 2013
    Inventors: Jack H. LADENSON, Omar LATERZA, Vijay MODUR
  • Alzheimer's diagnosis
    Patent number: 8481277
    Abstract: Evaluation of VLP-I levels in combination with at least one of amyloid-? peptide (AB), hyperphosphorylated tau (pTau) or total tau (tTau) levels in samples of biological fluid improves the accuracy of diagnosis of Alzheimer's disease.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: July 9, 2013
    Assignee: Washington University
    Inventors: Jack H. Ladenson, Omar Laterza, Vijay Modur
  • MARKERS FOR BRAIN DAMAGE
    Publication number: 20120021534
    Abstract: Methods to identify markers for brain damage using fresh brain tissue and methods and compositions for detecting these markers are disclosed.
    Type: Application
    Filed: July 20, 2011
    Publication date: January 26, 2012
    Applicant: Washington University
    Inventors: Jack LADENSON, Yvonne Landt, Vijay Modur, Omar Laterza
  • Markers for brain damage
    Patent number: 7985555
    Abstract: Methods to identify markers for brain damage using fresh brain tissue and methods and compositions for detecting these markers are disclosed.
    Type: Grant
    Filed: June 27, 2005
    Date of Patent: July 26, 2011
    Assignee: Washington University
    Inventors: Jack Ladenson, Yvonne Landt, Vijay Modur, Omar Laterza
  • ALZHEIMER'S DIAGNOSIS
    Publication number: 20110136254
    Abstract: Evaluation of VLP-I levels in combination with at least one of amyloid-? peptide (AB), hyperphosphorylated tau (pTau) or total tau (tTau) levels in samples of biological fluid improves the accuracy of diagnosis of Alzheimer's disease.
    Type: Application
    Filed: August 21, 2008
    Publication date: June 9, 2011
    Inventors: Jack H. Ladenson, Omar Laterza, Vijay Modur
  • Markers For Brain Damage
    Publication number: 20080131881
    Abstract: Methods to identify markers for brain damage using fresh brain tissue and methods and compositions for detecting these markers are disclosed.
    Type: Application
    Filed: June 27, 2005
    Publication date: June 5, 2008
    Inventors: Jack Ladenson, Yvonne Landt, Vijay Modur, Omar Laterza